Pharma Medica Research, Inc., a contract research organization serving the pharmaceutical and biotechnology industry, plans to make a $30.8 million capital investment and create 320 jobs at its first U.S. facility in St. Charles, Missouri. The Toronto-based company conducts research and development for pharmaceutical companies, as well as performs trials. They offer a wide range of services in this space including scientific affairs, medical writing, clinical conduct, bioanalysis, biostastics, data management, and clinical trial monitoring.
The company plans to rehabilitate a building in St. Charles that previously housed a clinical research organization to expand their drug trial operations. Earlier this year, Governor Nixon met with company officials at the 2013 International BIO Convention in Chicago to discuss opportunities for growth in Missouri. "The favorable business climate, quality workforce, and the close proximity to major pharmaceutical companies in the area were key factors in making the move to Missouri," said Mohammed Bouhajib of Pharma Medica Research, Inc. "With a new research center in St. Charles, we will be able to accommodate more clients and compete in the global market."